United States · FDA National Drug Code directory

GEMCITABINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63323-125_4c447f74-d06c-459b-ba63-6b72aaf4fd2e
Product NDC: 63323-125
Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term: GEMCITABINE
Labeler: Fresenius Kabi USA, LLC
Marketing category: ANDA
Marketing start / end (source format): 20110726
Source listing expiry: 20261231

Source-listed ingredients

GEMCITABINE HYDROCHLORIDE — 1 g/25mL

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL, SINGLE-DOSE in 1 BOX (63323-125-94) / 25 mL in 1 VIAL, SINGLE-DOSE · 63323-125-94

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →